中药及其复方抗肝纤维化作用机制的研究进展

被引:41
作者
吕超 [1 ]
毛德文 [2 ]
石清兰 [2 ]
覃倩 [1 ]
柏文婕 [1 ]
机构
[1] 广西中医药大学
[2] 广西中医药大学第一附属医院
关键词
中药; 肝纤维化; 作用机制; 研究进展;
D O I
暂无
中图分类号
R285 [中药药理学];
学科分类号
100806 [中药药理学];
摘要
肝纤维化是指由各种致病因子所致肝内结缔组织异常增生,导致肝脏中细胞外基质(ECM)的过度积累,纤维性瘢痕形成的病理过程。其持续恶化会逐步发展成肝硬化、肝衰竭、肝癌等严重肝脏疾病。由于肝纤维化及肝硬化早期可以逆转,因此控制肝纤维化这一可逆过程,对于肝硬化和肝癌的预防及治疗至关重要。近年来研究发现,中药治疗肝纤维化具有多靶点、毒副作用小、效果好等特点。该文对中药及其复方抗肝纤维化作用机制进行了归纳总结,包括中药可通过调节转化生长因子-β(TGF-β),血小板衍生生长因子(PDGF),血管内皮生长因子(VEGF),结缔组织生长因子(CTGF)等生长因子来抑制肝星状细胞(HSCs)活化和诱导活化的HSCs凋亡,促进脂联素的表达和抑制瘦素的分泌,抑制肝脏炎症反应,抗氧化应激,抑制肝窦内皮细胞毛细血管化等多个层面有效阻止肝纤维化的进展。因此中药能通过多机制和多层面抑制肝纤维化的发展,是治疗肝纤维化疾病的重要手段之一。
引用
收藏
页码:242 / 250
页数:9
相关论文
共 65 条
[1]
Reversibility of liver fibrosis.[J].Mengxi Sun;Tatiana Kisseleva.Clinics and Research in Hepatology and Gastroenterology.2015, S1
[2]
Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro.[J].Xuguang Zhai;Haowen Qiao;Wei Guan;Ziqiang Li;Yuanyuan Cheng;Xin Jia;Yajun Zhou.European Journal of Pharmacology.2015,
[3]
Adipocytokines and hepatic fibrosis [J].
Saxena, Neeraj K. ;
Anania, Frank A. .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2015, 26 (03) :153-161
[4]
Transforming Growth Factor-β–Independent Role of Connective Tissue Growth Factor in the Development of Liver Fibrosis.[J].Keiko Sakai;Safdar Jawaid;Takako Sasaki;George Bou-Gharios;Takao Sakai.The American Journal of Pathology.2014, 10
[5]
Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase [J].
Li, Jing ;
Pan, Yue ;
Kan, Mujie ;
Xiao, Xuanang ;
Wang, Yunjing ;
Guan, Fengying ;
Zhang, Xuewen ;
Chen, Li .
LIFE SCIENCES, 2014, 98 (01) :24-30
[6]
VEGFR and Type-V RTK Activation and Signaling [J].
Shibuya, Masabumi .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2013, 5 (10)
[7]
TGF-β signalling and its role in cancer progression and metastasis [J].
Yvette Drabsch ;
Peter ten Dijke .
Cancer and Metastasis Reviews, 2012, 31 :553-568
[8]
Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats [J].
Xie, Guanhua ;
Wang, Xiangdong ;
Wang, Lei ;
Wang, Lin ;
Atkinson, Roscoe D. ;
Kanel, Gary C. ;
Gaarde, William A. ;
DeLeve, Laurie D. .
GASTROENTEROLOGY, 2012, 142 (04) :918-U392
[9]
Liver fibrogenesis and metabolic factors.[J].Rodolphe Anty;Maud Lemoine.Clinics and Research in Hepatology and Gastroenterology.2011,
[10]
Few Smad proteins and many Smad-interacting proteins yield multiple functions and action modes in TGFβ/BMP signaling in vivo.[J].Andrea Conidi;Silvia Cazzola;Karen Beets;Kathleen Coddens;Clara Collart;Frederique Cornelis;Luk Cox;Debruyn Joke;Mariya P. Dobreva;Ruben Dries;Camila Esguerra;Annick Francis;Abdelilah Ibrahimi;Roel Kroes;Flore Lesage;Elke Maas;Ivan Moya;Paulo N.G. Pereira;Elke Stappers;Agata Stryjewska;Veronique van den Berghe;Liesbeth Vermeire;Griet Verstappen;Eve Seuntjens;Lieve Uman